This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Helix Biopharma Corporation. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Jodi Dickstein: Innovator in Cancer Treatment
Introduction
Jodi Dickstein is a prominent inventor based in Markham, Canada. She has made significant contributions to the field of cancer treatment through her innovative research and development of new methods and compositions aimed at inhibiting cancer cell growth. With a total of 2 patents, her work is paving the way for advancements in oncology.
Latest Patents
Jodi's latest patents focus on methods and compositions for inhibiting cancer cell growth. One of her notable inventions provides improvements in treating cancer with weakly basic anti-cancer compounds. This method involves exposing cancer cells to a urease enzyme composition, which reduces the amount of anti-cancer compound needed to achieve a desired level of growth inhibition. Additionally, her pharmaceutical compositions are designed for intravenous administration, enhancing the effectiveness of weakly basic anti-tumor compounds.
Career Highlights
Jodi Dickstein is currently associated with Helix Biopharma Corporation, where she continues to develop innovative solutions for cancer treatment. Her work is characterized by a commitment to improving therapeutic outcomes for patients suffering from various forms of cancer.
Collaborations
Throughout her career, Jodi has collaborated with notable colleagues, including Jerry McElroy and Heman Chao. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.
Conclusion
Jodi Dickstein's contributions to cancer treatment through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work continues to inspire advancements in medical science and offers hope for improved cancer therapies.